1,418
Views
1
CrossRef citations to date
0
Altmetric
Author's Views

Itraconazole perturbs colorectal cancer dormancy through SUFU-mediated WNT inhibition

ORCID Icon & ORCID Icon
Article: e1494950 | Received 14 Jun 2018, Accepted 27 Jun 2018, Published online: 07 Aug 2018

References

  • Guinney J, Dienstmann R, Wang X, de Reynies A, Schlicker A, Soneson C, Marisa L, Roepman P, Nyamundanda G, Angelino P, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21(11):1350–1356. PMID:26457759. doi:10.1038/nm.3967.
  • Sottoriva A, Kang H, Ma Z, Graham TA, Salomon MP, Zhao J, Marjoram P, Siegmund K, Press MF, Shibata D, et al. A Big Bang model of human colorectal tumor growth. Nature Genetics. 2015;47(3):209–216. PMID:25665006. doi:10.1038/ng.3214.
  • Kreso A, O’Brien CA, van Galen P, Gan OI, Notta F, Brown AM, Ng K, Ma J, Wienholds E, Dunant C, et al. Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer. Science. 2013;339(6119):543–548. PMID:23239622. doi:10.1126/science.1227670.
  • Buczacki SJ, Zecchini HI, Nicholson AM, Russell R, Vermeulen L, Kemp R, Winton DJ. Intestinal label-retaining cells are secretory precursors expressing Lgr5. Nature. 2013;495(7439):65–69. PMID:23446353. doi:10.1038/nature11965.
  • Buczacki SJA, Popova S, Biggs E, Koukorava C, Buzzelli J, Vermeulen L, Hazelwood L, Francies H, Garnett MJ, Winton DJ, Itraconazole targets cell cycle heterogeneity in colorectal cancer. J Exp Med. 2018; PMID:29853607. doi:10.1084/jem.20171385.
  • Shimokawa M, Ohta Y, Nishikori S, Matano M, Takano A, Fujii M, Date S, Sugimoto S, Kanai T, Sato T. Visualization and targeting of LGR5+ human colon cancer stem cells. Nature. 2017;545(7653):187–192. PMID:28355176. doi:10.1038/nature22081.
  • van Es JH, Sato T, van de Wetering M, Lyubimova A, Nee AN, Gregorieff A, Sasaki N, Zeinstra L, van den Born M, Korving J, et al. Dll1+ secretory progenitor cells revert to stem cells upon crypt damage. Nat Cell Biol. 2012;14(10):1099–1104. PMID:23000963. doi:10.1038/ncb2581.
  • Yauch RL, Gould SE, Scales SJ, Tang T, Tian H, Ahn CP, Marshall D, Fu L, Januario T, Kallop D, et al. A paracrine requirement for hedgehog signalling in cancer. Nature. 2008;455(7211):406–410. PMID:18754008. doi:10.1038/nature07275.
  • Kim J, Tang JY, Gong R, Kim J, Lee JJ, Clemons KV, Chong CR, Chang KS, Fereshteh M, Gardner D, et al. Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth. Cancer Cell. 2010;17(4):388–399. PMID:20385363. doi:10.1016/j.ccr.2010.02.027.
  • Regan JL, Schumacher D, Staudte S, Steffen A, Haybaeck J, Keilholz U, Schweiger C, Golob-Schwarzl N, Mumberg D, Henderson D, et al. Non-Canonical Hedgehog Signaling Is a Positive Regulator of the WNT Pathway and Is Required for the Survival of Colon Cancer Stem Cells. Cell Rep. 2017;21(10):2813–2828. PMID:29212028. doi:10.1016/j.celrep.2017.11.025.